These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 3304966)

  • 1. Cefmenoxime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
    Campoli-Richards DM; Todd PA
    Drugs; 1987 Aug; 34(2):188-221. PubMed ID: 3304966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ceftizoxime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
    Richards DM; Heel RC
    Drugs; 1985 Apr; 29(4):281-329. PubMed ID: 3888599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the in vitro and in vivo antibacterial activities of cefepime (BMY-28142) with ceftazidime, cefuzonam, cefotaxime and cefmenoxime.
    Masuyoshi S; Hiraoka M; Inoue M; Tomatsu K; Hirano M; Mitsuhashi S
    Drugs Exp Clin Res; 1989; 15(1):1-10. PubMed ID: 2663406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ceftriaxone. A review of its antibacterial activity, pharmacological properties and therapeutic use.
    Richards DM; Heel RC; Brogden RN; Speight TM; Avery GS
    Drugs; 1984 Jun; 27(6):469-527. PubMed ID: 6329638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laboratory evaluation of cefmenoxime: a new cephalosporin. In vitro and in vivo antibacterial activities and pharmacokinetic properties.
    Matsumoto K; Nagatake T; Uzuka Y; Harada T; Rikitomi N
    Chemotherapy; 1983; 29(2):80-8. PubMed ID: 6301776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cefotaxime. A review of its antibacterial activity, pharmacological properties and therapeutic use.
    Carmine AA; Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1983 Mar; 25(3):223-89. PubMed ID: 6303743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ceftizoxime: a beta-lactamase-stable, broad-spectrum cephalosporin. Pharmacokinetics, adverse effects and clinical use.
    Neu HC
    Pharmacotherapy; 1984; 4(2):47-60. PubMed ID: 6326062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cefmenoxime. Clinical, bacteriologic, and pharmacologic studies.
    LeFrock JL; Molavi A; McCloskey RV; Rolston K; Chandrasekar P; Henao L; Smith BR; Kannangara W; Schell RF; Carr BB
    Am J Med; 1984 Jul; 77(1):72-8. PubMed ID: 6331163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity and beta-lactamase stability of cefmenoxime.
    Neu HC; Labthavikul P
    Antimicrob Agents Chemother; 1982 Aug; 22(2):316-22. PubMed ID: 6100427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The third generation cephems for surgical infections].
    Ishibiki K; Aikawa N
    Nihon Geka Gakkai Zasshi; 1984 Sep; 85(9):1133-7. PubMed ID: 6095017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Experimental and clinical studies of cefmenoxime in the field of obstetrics and gynecology].
    Takase Z; Noda K; Hayasaki M; Iwasa S; Motomura R; Yamabe T; Ichinohe K; Kutsuzawa T; Kaneko M; Domon H; Kodama M; Shimizu T; Mizoguchi H; Yorozu Y; Maki M; Chimura T; Matsuda S; Cho N; Fukunaga K; Kunii K; Wagatsuma T; Kaku R; Hogaki M; Ikawa M; Matsumoto Y; Fukuoka H; Honma T; Sanada K; Minakuchi H; Sumiyoshi Y; Hayashi S; Nakamura H; Goto T; Ihara Y; Hagiwara K; Tsuruta S; Yabuki A; Higashide K; Hasegawa Y; Ninomiya K; Okada H; Kanao M; Yasuda J; Takashima E; Ikeuchi M; Kobayashi Y; Haruta T; Hirabayashi K; Doko F; Watanabe K
    Jpn J Antibiot; 1982 Jun; 35(6):1585-609. PubMed ID: 6290708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [In vitro bacteriostatic activity of cefmenoxime (SCE 1365), cefotaxime and moxalactam].
    Husson MO; Bryskier A; Izard D; Leclerc H
    Pathol Biol (Paris); 1983 May; 31(5):347-50. PubMed ID: 6312395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapeutic effects of cefmenoxime in the treatment of various infections on infants and children].
    Kurashige T; Wakiguchi H; Kitamura I; Ozaki H; Nishibayashi Y; Hamawaki M
    Jpn J Antibiot; 1982 Nov; 35(11):2579-88. PubMed ID: 6302339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cefmenoxime (SCE-1365), a new cephalosporin: in vitro activity, comparison with other antimicrobial agents, beta-lactamase stability, and disk diffusion testing with tentative interpretive criteria.
    Fuchs PC; Jones RN; Thornsberry C; Barry AL; Gerlach EH; Sommers HM
    Antimicrob Agents Chemother; 1981 Dec; 20(6):747-59. PubMed ID: 6275784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-lactamase stability and antibacterial activity of cefmenoxime (SCE-1365), a novel cephalosporin.
    Okonogi K; Kuno M; Kida M; Mitsuhashi S
    Antimicrob Agents Chemother; 1981 Aug; 20(2):171-5. PubMed ID: 6269488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [In vitro activity of cefmenoxime (SCE 1365) against 616 hospital strains of gram-negative bacilli chosen for beta-lactam resistance. Comparison with cefotaxime, lamoxactam and ceftazidime].
    Le Noc P; Bryskier A; Le Noc D
    Pathol Biol (Paris); 1983 May; 31(5):351-6. PubMed ID: 6312396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial activity of cefmenoxime compared with those of other cephalosporins.
    Schell RF; Smith BR; LeFrock JL; Francisco MA
    Antimicrob Agents Chemother; 1983 May; 23(5):774-7. PubMed ID: 6307136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-vitro antibacterial activity of L-105, a new cephalosporin.
    Hikida M; Inoue M; Mitsuhashi S
    J Antimicrob Chemother; 1986 Nov; 18(5):585-91. PubMed ID: 3492485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cefotaxime. An update of its pharmacology and therapeutic use.
    Todd PA; Brogden RN
    Drugs; 1990 Oct; 40(4):608-51. PubMed ID: 2083516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disulfiram-like reactions with newer cephalosporins: cefmenoxime.
    Kannangara DW; Gallagher K; Lefrock JL
    Am J Med Sci; 1984; 287(2):45-7. PubMed ID: 6324592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.